RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCIE SCOPUS

      15d-PGJ2 inhibits NF-kB and AP-1-mediated MMP-9 expression and invasion of breast cancer cell by means of a heme oxygenase-1-dependent mechanism

      한글로보기

      https://www.riss.kr/link?id=A106839252

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Activation of peroxisome proliferator-activated receptor  (PPAR) serves as a key factor in the proliferation and invasion of breast cancer cells and is a potential therapeutic target for breast cancer. However, the mechanisms underlying this eff...

      Activation of peroxisome proliferator-activated receptor  (PPAR) serves as a key factor in the proliferation and invasion of breast cancer cells and is a potential therapeutic target for breast cancer.
      However, the mechanisms underlying this effect remain largely unknown. Heme oxygenase-1 (HO-1) is induced and overexpressed in various cancers and is associated with features of tumor aggressiveness. Recent studies have shown that HO-1 is a major downstream target of PPAR. In this study, we investigated the effects of induction of HO-1 by PPAR on TPAinduced MMP-9 expression and cell invasion using MCF-7 breast cancer cells. TPA treatment increased NF-B /AP-1 DNA binding as well as MMP-9 expression. These effects were significantly blocked by 15d-PGJ2, a natural PPAR ligand. 15d-PGJ2 induced HO-1 expression in a dose-dependent manner. Interestingly, HO-1 siRNA significantly attenuated the inhibition of TPA-induced MMP-9 protein expression and cell invasion by 15d-PGJ2.
      These results suggest that 15d-PGJ2 inhibits TPA-induced MMP- 9 expression and invasion of MCF-7 cells by means of a heme oxygenase-1-dependent mechanism. Therefore, PPAR/HO-1 signaling- pathway inhibition may be beneficial for prevention and treatment of breast cancer.

      더보기

      참고문헌 (Reference)

      1 Su Z, "Tumor promoter TPA activates Wnt/beta-catenin signaling in a casein kinase 1-dependent manner" 115 : E7522-E7531, 2018

      2 Gould CM, "The life and death of protein kinase C" 9 : 614-625, 2008

      3 Lee WY, "The induction of heme oxygenase-1 suppresses heat shock protein 90 and the proliferation of human breast cancer cells through its byproduct carbon monoxide" 274 : 55-62, 2014

      4 Tsubaki M, "Pioglitazone inhibits cancer cell growth through STAT3 inhibition and enhanced AIF expression via a PPARgamma-independent pathway" 233 : 3638-3647, 2018

      5 Diradourian C, "Phosphorylation of PPARs : from molecular characterization to physiological relevance" 87 : 33-38, 2005

      6 Ono Y, "Phorbol ester binding to protein kinase C requires a cysteine-rich zincfinger-like sequence" 86 : 4868-4871, 1989

      7 Kourtidis A, "Peroxisome proliferator-activated receptor-gamma protects ERBB2-positive breast cancer cells from palmitate toxicity" 11 : R16-, 2009

      8 Wang X, "PPARgamma maintains ERBB2-positive breast cancer stem cells" 32 : 5512-5521, 2013

      9 Liu H, "PPARgamma ligands and ATRA inhibit the invasion of human breast cancer cells in vitro" 79 : 63-74, 2003

      10 Robbins GT, "PPAR gamma, bioactive lipids, and cancer progression" 17 : 1816-1834, 2012

      1 Su Z, "Tumor promoter TPA activates Wnt/beta-catenin signaling in a casein kinase 1-dependent manner" 115 : E7522-E7531, 2018

      2 Gould CM, "The life and death of protein kinase C" 9 : 614-625, 2008

      3 Lee WY, "The induction of heme oxygenase-1 suppresses heat shock protein 90 and the proliferation of human breast cancer cells through its byproduct carbon monoxide" 274 : 55-62, 2014

      4 Tsubaki M, "Pioglitazone inhibits cancer cell growth through STAT3 inhibition and enhanced AIF expression via a PPARgamma-independent pathway" 233 : 3638-3647, 2018

      5 Diradourian C, "Phosphorylation of PPARs : from molecular characterization to physiological relevance" 87 : 33-38, 2005

      6 Ono Y, "Phorbol ester binding to protein kinase C requires a cysteine-rich zincfinger-like sequence" 86 : 4868-4871, 1989

      7 Kourtidis A, "Peroxisome proliferator-activated receptor-gamma protects ERBB2-positive breast cancer cells from palmitate toxicity" 11 : R16-, 2009

      8 Wang X, "PPARgamma maintains ERBB2-positive breast cancer stem cells" 32 : 5512-5521, 2013

      9 Liu H, "PPARgamma ligands and ATRA inhibit the invasion of human breast cancer cells in vitro" 79 : 63-74, 2003

      10 Robbins GT, "PPAR gamma, bioactive lipids, and cancer progression" 17 : 1816-1834, 2012

      11 Jung Hyun Park, "Melittin Suppresses PMA-Induced Tumor Cell Invasion by Inhibiting NF-κB and AP-1-Dependent MMP-9 Expression" 한국분자세포생물학회 29 (29): 209-215, 2010

      12 Jablonska-Trypuc A, "Matrix metalloproteinases(MMPs), the main extracellular matrix(ECM)enzymes in collagen degradation, as a target for anticancer drugs" 31 : 177-183, 2016

      13 Srivastava N, "Inhibition of cancer cell proliferation by PPARgamma is mediated by a metabolic switch that increases reactive oxygen species levels" 20 : 650-661, 2014

      14 Lin CW, "Heme oxygenase-1 inhibits breast cancer invasion via suppressing the expression of matrix metalloproteinase-9" 7 : 1195-1206, 2008

      15 Wu ML, "Heme oxygenase-1 in inflammation and cardiovascular disease" 1 : 150-158, 2011

      16 Maines MD, "Heme oxygenase : function, multiplicity, regulatory mechanisms, and clinical applications" 2 : 2557-2568, 1988

      17 이하나, "Heme Oxygenase-1 Determines the Differential Response of Breast Cancer and Normal Cells to Piperlongumine" 한국분자세포생물학회 38 (38): 327-335, 2015

      18 Vanella L, "HO-1expression increases mesenchymal stem cell-derived osteoblasts but decreases adipocyte lineage" 46 : 236-243, 2010

      19 박소연, "HO-1 Induced by Cilostazol Protects Against TNF-α-Associated Cytotoxicity via a PPAR-γ-Dependent Pathway in Human Endothelial Cells" 대한약리학회 15 (15): 83-88, 2011

      20 Kohrmann A, "Expression of matrix metalloproteinases(MMPs)in primary human breast cancer and breast cancer cell lines : New findings and review of the literature" 9 : 188-, 2009

      21 Pellikainen JM, "Expression of matrix metalloproteinase(MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis" 10 : 7621-7628, 2004

      22 Kronke G, "Expression of heme oxygenase-1 in human vascular cells is regulated by peroxisome proliferator-activated receptors" 27 : 1276-1282, 2007

      23 Yokoo T, "Dual regulation of IL-1beta-mediated matrix metalloproteinase-9 expression in mesangial cells by NF-kappa B and AP-1" 270 : F123-130, 1996

      24 Kim HJ, "Curcumin suppresses migration and proliferation of Hep3B hepatocarcinoma cells through inhibition of the Wnt signaling pathway" 8 : 282-286, 2013

      더보기

      동일학술지(권/호) 다른 논문

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      학술지등록 한글명 : BMB reports
      외국어명 : BMB reports
      2024 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2021-01-01 평가 등재학술지 선정 (해외등재 학술지 평가) KCI등재
      2020-12-01 평가 등재후보로 하락 (해외등재 학술지 평가) KCI등재후보
      2013-07-17 학술지명변경 한글명 : BMB reports -> BMB Reports
      외국어명 : BMB reports -> BMB Reports
      KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2009-09-21 학회명변경 한글명 : 대한생화학ㆍ분자생물학회 -> 생화학분자생물학회
      영문명 : Korean Society Of Medical Biochemistry And Molecular Biology -> Korean Society Of Biochemistry And Molecular Biology
      KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2007-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2005-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2002-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      1999-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 2.76 0.5 1.94
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      1.45 1.12 0.646 0.12
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼